Annual report pursuant to Section 13 and 15(d)

12. Stock Compensation (Tables)

v3.19.1
12. Stock Compensation (Tables)
 12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of stock grant activity
Total Grants awarded as of December 31, 2017     310,000  
Grants awarded     2,141,500  
Forfeiture/Cancelled     90,000  
Grants vested     558,833  
Total Grants awarded as of December 31, 2018     1,802,667  
Schedule of stock grant vesting periods
       
Amount of Shares     Year Ending December 31,
  688,499     2019
  632,500     2020
  481,668     2021
  1,802,667      
Schedule of stock option activity
    Number of
Shares		     Weighted Average Remaining
Life (Years)		     Weighted Average
Exercise
Price		  
Stock options outstanding as of December 31, 2017     –       –       –  
Issued     1,259,000                  
Exercised     –                  
Expired     75,000                  
Stock options outstanding at December 31, 2018     1,184,000       9.68     $ 1.15  
Stock options exercisable at December 31, 2018     100,000                  
Schedule of stock option vesting periods
Number of Shares    

Year Ending

December 31,
  415,830     2019
  385,831     2020
  282,339     2021
  1,084,000